Be a Smart Investor
Wednesday, August 24, 2016
Pfizer to buy antibiotics business from AstraZeneca
AstraZeneca has agreed to sell its small molecule antibiotics business to Pfizer in a deal that could be valued at more than $1.5 billion.
from Mergers and Acquisitions http://ift.tt/2bmLfmG
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment